Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine

Completed · Phase 1

Conditions studied: Healthy

In brief

This is an open label, single-center study to determine the absolute bioavailability and nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.

Key facts

Study ID

NCT00520169

Run by

Javelin Pharmaceuticals

People needed

32

Starts

2007-07-01

Expected to finish

2007-09-01

Last updated by the study team

2008-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults

You may not qualify if…

• under 18 years

Where it is running

• Javelin Pharmaceuticals — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.